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Abstract
G-Protein Coupled Receptors (GPCRs) play a critical role in cellular signal transduction pathways 
and are prominent therapeutic targets. Recently there has been major progress in obtaining 
experimental structures for a few GPCRs. Each GPCR, however, exhibits multiple conformations 
that play a role in their function and we have been developing methods aimed at predicting 
structures for all these conformations. Analysis of available structures shows that these 
conformations differ in relative helix tilts and rotations. The essential issue is, determining how to 
orient each of the 7 helices about its axis since this determines how it interacts with the other 6 
helices. Considering all possible helix rotations to ensure that no important packings are 
overlooked, and using rotation angle increments of 30° about the helical axis would still lead to 
127 or 35 million possible conformations each with optimal residue positions. We show in this 
paper how to accomplish this. The fundamental idea is to optimize the interactions between each 
pair of contacting helices while ignoring the other 5 and then to estimate the energies of all 35 
million combinations using these pair-wise interactions. This BiHelix approach dramatically 
reduces the effort to examine the complete set of conformations and correctly identifies the crystal 
packing for the experimental structures plus other near-native packings we believe may play an 
important role in activation. This approach also enables a detailed structural analysis of 
functionally distinct conformations using helix-helix interaction energy landscapes and should be 
useful for other helical transmembrane proteins as well.
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1. Introduction
The G protein-coupled receptors (GPCRs) form the largest superfamily of integral 
membrane proteins and comprise of seven transmembrane (TM) α-helices. The GPCRs are 
activated by a variety of bioactive molecules, like biogenic amines, peptides, lipids, 
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nucleotides, proteins, tastants, odorants and non-molecular sensory signals like light, touch 
etc, making them essential for a range of physiological processes (e.g. neurotransmission, 
cellular metabolism, secretion, cell growth, immune defense, and differentiation).1,2 Besides 
G proteins, these receptors couple to β-arrestins for signaling.3 The receptors have also been 
shown to couple exclusively to β-arrestins4-6 (in a G protein independent manner) and hence 
are also referred to as 7TM proteins.
It is well established that the process of GPCR activation7-11 involves a sequence of 
conformational changes that enable the cell to convert extracellular signals into 
physiological responses and is at the heart of their pleiotropic nature as nicely reviewed 
recently by Kenakin and Miller.12 GPCR activation also occurs spontaneously in the 
absence of any signal (called constitutive activity) due to inherent conformational flexibility 
of these receptors.13 Kenakin has provided a conceptual framework to think about these 
signal-induced and signal-independent conformational changes in terms of shifting energy 
landscapes and transforming ensemble of conformations.14,15 Strong experimental evidence 
for this flexibility includes fluorescence lifetime measurements that have identified distinct 
ligand-induced conformational states for the β2-Adrenergic Receptor (β2AR) along the 
activation pathways10, as well as the recently crystallized agonist-bound conformation of 
β2AR stabilized by a G protein mimicking nanobody.16 Single point mutations have also 
been shown to induce constitutively more-active conformations.17,18 Thus, to fully gain 
structural insight into the pleiotropic function of GPCRs will require the functional 
characterization of their multiple conformations to highlight how different ligands or 
mutations modulate (stabilize and/or induce) conformations to cause their effects.12,19-22
In the last few years there has been a rapid increase in the solution of crystal structures for 
many GPCRs16,23-31 due mainly to a technological revolution in membrane protein structure 
determination methods.32 The topological comparison of these crystal structures and their 
implications for GPCR activation has been reviewed extensively33-37. All GPCR 
conformations observed so far have corresponded to the inactive state of the respective 
receptor, except for bovine opsin28 and nanobody stabilized human β2AR bound to an 
agonist16. Structure determination efforts are moving towards the stabilization of GPCRs in 
different functional conformations (e.g., bound to agonists, G proteins or β arrestins), and 
structural computational biology can help by mapping the energy landscape sampled by 
GPCRs during their life-cycle and characterizing the critical conformations along the way to 
link with those that are observed in experimental structures.
Homology based computational methods have had successes with soluble proteins where 
there may be experimental structures for a variety of similar proteins, particularly where the 
homology is above 30%,38 although it is not clear whether such structures are sufficiently 
accurate for drug design, though they may be accurate enough to be helpful in virtual ligand 
screening (VLS) efforts39,40, in addition to those obtained from de novo methods, which 
have been successful in VLS efforts as well as in correctly predicting structure-activity 
relationships41,42. The homology methods do not appear to be a viable alternative (yet) for 
predicting multiple GPCR conformations due to the very limited conformational sampling 
(if any) that is done to predict structures and will require significant modifications to be able 
to predict multiple diverse conformations for a GPCR. Homology models may be good for 
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obtaining structures of very closely related receptors (like dopamine D2 from dopamine D3) 
and that too only for the same functional form (inactive form or one of many active GPCR 
forms) as that of the template, but homology modeling doesn’t provide a recipe to obtain 
multiple low-energy conformations, which the BiHelix approach is targeting and which is 
essential to describe GPCR activation and function.
The conformational flexibility associated with GPCRs can, however, be targeted by 
structure prediction methods that sample and identify all low energy (physiologically 
important) conformations for a GPCR. The lipid bilayer environment of the plasma 
membrane forces specific boundary conditions on these structures and how they fold. In 
contrast to the almost immeasurable ways of sampling tertiary conformations of soluble 
proteins, the tertiary structure of GPCRs with seven almost-parallel TM α-helices allows 
one to quantify the conformational space available to these TM bundles as will be shown in 
the next section. Molecular events like the binding of ligands or G proteins or β arrestins to 
GPCRs as well as point mutations in GPCRs will cause a different sampling of this available 
space and stabilize different sets of conformations. Methods based mainly on molecular 
dynamics (MD) are ill-positioned to sample all relevant conformations due to the large 
dimensionality of the energy landscape and high energetic barriers to access a diverse set of 
conformations. MD simulations are ideal to test the stability of GPCR structures (predicted 
or crystal structures) in their local minima, though it takes a long time and lot of effort to 
establish convergence43.
Knowledge-based methods have been developed to predict GPCR structures44-46 and their 
ability to predict structures for GPCRs distant from the templates remains to be seen. The 
Membstruk47,48 and PREDICT49 methods tried to sample TM helix bundles as well but do 
very coarse sampling. The Membstruk method sampled helix rotation angles on a 5° grid but 
didn’t sample anyway near the complete conformational space of the BiHelix approach 
presented here, because when a helix underwent rotation from 0° to 360°, the other 6 helices 
were held at 0°. So, the conformational space sampled in Membstruk was 72 × 7 ~ 504 
conformations compared to the ~35 million or ~4.5 billion conformations sampled by the 
BiHelix approach in this work. The PREDICT method sampled and refined structures 
obtained from templates/decoys generated by placing the 7 helices as 7 discs on a 2-D plane 
in different possible topologies. The decoys sampled a highly unrealistic helix packing space 
as evidenced by the fact that their most stable helix packing for dopamine D2 receptor (Fig. 
3 in ref.49) shows TM7 in the middle which is at odds with all the GPCR crystal structures 
observed so far (including the very closely related one for dopamine D3 receptor29) all of 
which show TM3 in the middle.
Monte carlo (MC) type methods have the best chance to sample the conformational space 
allowed to GPCRs by the lipid-bilayer of the membranes as long as they can ensure a 
complete sampling of this available conformational space because MC methods cannot 
guarantee the complete sampling of this space. If we take, as an example, the space of helix 
rotations in the TM bundles of GPCRs, our previous approaches to predict the structures of 
GPCRs indicated that one needs to sample rotations of each helix at increments no larger 
than 30° to identify important helical packings. Since we want to make sure that we sample 
all possible conformations in this space, this suggests that we should consider 127 ~ 
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35,000,000 possible packings (using a 30° grid in the full rotational space from 0° to 360° 
for all seven helices). Packing such a huge number of conformations into 7-helix bundles, 
optimizing the side chains for each, and evaluating the energy after removing bad contacts 
would be an enormous undertaking. This paper introduces the BiHelix method that enables a 
complete sampling of this huge conformational space at a very modest computational cost. 
We illustrate this approach with a demonstration of the efficiency of a complete sampling of 
the helical rotational degree of freedom (DOF) using six of the available GPCR crystal 
structures. It will also be shown how this sampling can begin to identify other functionally 
important GPCR conformations and also enable an analysis of the functionally distinct 
conformations through helix-helix energy potential landscapes.
The efficiency of the BiHelix method will become even more critical when we sample helix 
tilts (see next section for definitions) in addition to helix rotations, which increases the 
available conformational space to > 10 trillion conformations. Even though this method has 
been demonstrated for GPCRs, it is directly applicable to helical membrane proteins in 
general and also has the potential to assist with some of the challenges associated with the 
TM helix cores that lie ahead for the prediction of membrane protein structures.50
2. Materials and Methods
2.A Coordinate System
To characterize the conformational space available to GPCRs, we need to define a reference 
frame (relative to the plasma membrane) and a set of coordinates that uniquely define the 
orientation of each of the seven α-helices in the TM bundle. As crystal structures don’t 
provide absolute membrane orientation of GPCRs, we use their orientation as predicted by 
the OPM (Orientation of Proteins in Membrane) database,51 which aligns each newly 
deposited membrane protein structure to an implicit membrane. During this alignment, it 
optimizes the membrane width as well as tilt of the whole protein relative to the membrane 
middle to maximize the free energy of protein’s insertion into the membrane. The middle of 
the membrane corresponds to the z=0 plane and will be called the hydrophobic plane.
Each GPCR structure can then be characterized by the six orientation parameters of the 
seven α-helices relative to this plane. Figure 1 shows how the helix position and tilt are 
defined. Helix position (R) on the hydrophobic plane is given by x and y. The h value for a 
helix refers to the hydrophobic center residue of the helix and specifies the helix residue that 
intersects with the z=0 or hydrophobic plane described above. Two angles, θ and ϕ specify 
the tilt angles of the as yet undefined helical axis and the angle η corresponds to the helix 
rotation angle about this axis. The two tilt angles (θ,ϕ) and the rotation angle (η) require a 
unique definition of the helical axis which also account for the reality of bent helices caused 
mainly by Proline residues in the middle of TM helices. We use a helical axis that 
corresponds to the least moment of inertia vector for the helix, obtained by diagonalizing the 
moment of inertia matrix for the helix using only heavy backbone atoms.
In this coordinate system, each GPCR conformation will be represented by 42 numbers (6 
orientation parameters defined above for each of the seven helices). In a GPCR structure 
prediction problem, two scenarios typically arise:
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a. Structure for one conformation is available for a GPCR, usually in the inactive 
form from solving the crystal structure. This will be an ideal starting template for 
sampling to characterize the conformational changes possible in this GPCR as part 
of its function and ligand binding properties. During this sampling, it is likely that 
only a small subset of orientation parameters (out of 42) may need to be sampled 
locally around the starting template.
b. Structure is available for one conformation of a GPCR closely related to the target 
GPCR. That template conformation, mutated to reflect the residues in the target 
GPCR, becomes the starting template for sampling to characterize the potential 
conformational changes in the target GPCR. During this sampling, probably a 
larger subset of orientation parameters (compared to the previous case) may need to 
be sampled over a bigger range locally around the starting template.
2.B Starting TM Bundle
The BiHelix method, described in the next section, predicts the lowest energy structures in 
the conformational space being sampled. As mentioned in the previous section, the starting 
structure for sampling can be obtained either from a known conformation (e.g., from crystal 
structure) or from a homology structure based on a related protein structure. To demonstrate 
the BiHelix method, we use 6 of the available GPCR structures: bovine rhodopsin (PDB ID: 
1u19)52, hβ2-AR (2rh1)24, hA2AR (3eml)25, turkey β1-AR (2vt4)26, bovine opsin (3cap)28, 
and squid rhodopsin (2z73)27. The PDB structures aligned to the membrane from the OPM 
database51, are minimized using the Dreiding force-field (FF)53 and their loop regions are 
removed leaving the GPCR bundles with only full length TM helices. These TM bundles 
serve as starting structures for the BiHelix sampling that is to be described next.
2.C BiHelix Sampling
The BiHelix sampling method deals with the optimization of the TM helix bundles and 
implicitly assumes that this optimization is not affected by the loops that connect the TM 
regions, although the effect of this assumption remains to be seen. This is a reasonable 
assumption as the loop regions are flexible compared to the TM regions and can potentially 
adapt to any TM bundle conformation that has strong TM bundle interactions. We anticipate 
that in the full sampling of all helix orientation angles (θ,ϕ,η) for the seven helices 
(conformational space ~10 trillion) loop closure condition can potentially eliminate the 
disallowed TM bundle packings by restricting the sampling space and make it 
computationally tractable.
For each of the starting templates mentioned in the previous section, we will need to 
determine the optimum orientation parameters (x, y, h, θ, ϕ, η) for the packing of each of the 
7 helices into a 7-helix bundle. Complete sampling of these 42 parameters is neither 
practical nor the most efficient. The availability of many starting templates provides a good 
initial sampling of the x,y space. The parameter h or the hydrophobic center can be obtained 
from the starting template or from the estimation of the buoyant center of a TM helix from a 
hydrophobic profile (part of a new TM helix prediction algorithm to be covered in a 
forthcoming publication). So, one would need to sample helix orientation angles (θ, ϕ, η) for 
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each of the 7 helices. The BiHelix sampling methodology will now be described and 
demonstrated using the helix rotation angle (η) as the DOF being sampled. The sampling 
method is independent of the number of DOFs being sampled.
Consider a 30° sampling of the η angle (keeping θ and φ fixed) for each of the 7 helices over 
full 360°, which leads to (12)7 ~ 35 million conformations, for each of which the side chains 
must be optimized. This number reaches trillions of conformations if all three angles (θ, ϕ, 
η) were being sampled. To make such a huge sampling computationally tractable, we 
devised the BiHelix sampling procedure. A typical class A GPCR template is shown in 
Figure 2A. It has 12 nearest-neighbor helix pairs shown by double arrows in Figure 2B. 
Since helix pairs 1-3, 1-4, 1-5, 1-6, 2-5, 2-6, etc don’t interact with each other, such pairs of 
helices don’t need to be sampled. In the BiHelix procedure, the seven-helix bundle is split 
into 12 two-helix bundles comprising of nearest-neighbor helices shown explicitly in Figure 
2C, whose conformational space can be sampled completely, during which other five helices 
are not present.
Using the sampling of rotational angle η as an example, each two-helix bundle will sample 
(12)2 = 144 conformations (using a 30° grid over full 360°). Each of these conformations is 
built for which the side chains need to optimized now. We use the SCREAM method54 that 
uses an updated DREIDING force field (FF)53 (referred to as DREIDING-III or D3FF). The 
energy functions based on D3FF don’t include the effects of the nonpolar environment 
because we have found (data not shown) that accounting of this environment only reorders 
the protein conformations locally and doesn’t affect the overall conformational preference of 
the structures.
SCREAM uses a library of residue conformations ranging from a CRMS diversity of 0.4Å 
to 1.6Å in conjunction with a Monte Carlo sampling using full valence, hydrogen bond and 
electrostatic interactions from D3FF, but with a special flat bottom van der Waals (vdW) 
potentials that reduces the penalty for contacts that are slightly too short while retaining the 
normal attractive interactions at full strength. To benefit from this penalty, the two-helix 
bundle with SCREAM optimized side-chains is minimized for 10 steps using a conjugate 
gradient (CG) method. The resulting D3FF energy is accurate enough to correctly select the 
best cases (without separate considerations of valence, electrostatic, hydrogen bond and 
vdW terms) as will be seen in the results.
This sampling is done for all 12 nearest-neighbor helix pairs mentioned earlier resulting in 
(12)×(144) =1728 energies, which can be combined to estimate the energy of all possible 
~35 million (12)7 conformations in our sampling demonstration as follows. Each of the 1728 
energies corresponds to a specific helix pair i-j, for a specific combination of ηi and ηj and is 
reported in the form of three energy components:
a.
 (ηi,ηj): This component corresponds to interhelical energy of the helix 
pair that describes the total interaction energy between the helices. It is calculated 
by subtracting the internal energy of individual helices from the total energy of the 
two interacting helices and captures sidechain-sidechain, sidechain-backbone, 
backbone-backbone interactions across the two helices.
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b.
 (ηi,ηj): This component refers to the intrahelical energy of helix i 
while it is interacting with helix j in the i-j pair.
c.
 (ηi,ηj): This component refers to the intrahelical energy of helix j 
while it is interacting with helix i in the i-j pair.
The interhelical component of the energy is additive and can be summed to give the total 
interhelical energy of a seven-helix bundle. The intrahelical component of helix 3, for 
example, in the 2-3 helix pair will in general be different from that in the 3-4 helix pair. To 
accommodate this, the intrahelical energy of a helix in the seven-helix bundle is 
approximated as the average of that energy from all helix-pairs involving that helix. Using 
this “mean-field” approximation, the energy of the ~35 million conformations for the seven-
helix bundle can be estimated. The corresponding equations are shown in Equations (1) 
through (3). where Ni is the number of helix pairs involving helix i, and J1 through JNi are 
the helix partners of helix i in those Ni pairs. The ordering of the energies of all ~35 million 
conformations can be used to select top M (typically 1000 or 2000) seven-helix 
conformations to be built explicitly and reordered using more accurate energies in the next 
step (as will be described), because until this point, only two-helix bundles have been 
optimized in the absence of other five helices.
(1)
(2)
(3)
2.D CombiHelix Rotational Sampling
In the CombiHelix step, the top M structures from the BiHelix analysis are built explicitly 
using the rotations specified for each helix in the combination. The helical axis for rotation 
is identical to the one used in BiHelix. For each bundle, the side chains are optimized using 
SCREAM54 as described in the previous section. This is followed by 10 steps of CG 
minimization.
The energy function in this CombiHelix stage refers to the energy of the full seven-helix 
bundle whose residue side-chains were optimized and the resulting structure minimized. The 
energy function in the BiHelix stage estimated the energy of the seven-helix bundle by 
combining the energies of the nearest-neighbor two-helix bundles (with optimized side-
chains) using Equations (1) through (3). So, the energy of a seven-helix bundle at the 
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CombiHelix stage is expected to be more accurate than at the BiHelix stage. The resulting 
energies are reordered to provide a new thermodynamic ranking of the M structures taken 
from BiHelix and the resulting lowest energy conformations can be analyzed in the context 
of the conformational space that was sampled, (e.g., η for all seven helices).
In the next section, this BiHelix/CombiHelix procedure will be applied to six of the GPCR 
crystal templates, to show that the complete sampling scheme works and that the energies 
are reliable enough to produce near-native GPCR conformations as ones with the lowest 
energy. Rhodopsin has been crystallized in ligand-free form (Opsin)28 which has a different 
TM helix packing. These two systems will be used in the next section to analyze the results 
of the BiHelix methodology in terms of understanding their functional differences on the 
basis of structure. The methodology also lends itself to analyzing helix-helix interactions 
using potential energy landscapes that can provide additional insights into the function of 
these receptors.
3. RESULTS and DISCUSSION
3.A Validation of BiHelix/CombiHelix Sampling and Energy Function
For validation, we have applied this procedure to six of the available GPCR crystal 
structures: bovine rhodopsin (PDB ID: 1u19)52, hβ2-AR (2rh1)24, hA2AR (3eml)25, turkey 
β1-AR (2vt4)26, bovine opsin (3cap)28, squid rhodopsin (2z73)27. The TM seven-helix 
bundles for the application of the computational procedure were obtained as described in 
section 2.B.
In the first demonstration of BiHelix, we compared energies obtained for three-helix bundles 
extracted from hβ2-AR and hA2AR using the BiHelix approximation and the corresponding 
exact energies from a full sampling of three-helix (trihelix) conformations. These energies 
were obtained for all possible rotations of 3 helices at 30° increment (12^3=1728 
conformations) for the following six trihelices: H1-H2-H7, H2-H3-H4, H2-H3-H7, H3-H4-
H5, H3-H5-H6, and H3-H6-H7. The trihelix energies are compared to those obtained by a 
BiHelix mean-field approximation utilizing three BiHelix pairs and the results are shown in 
three supplementary Figures S1, S2, and S3. Figure S1 has results for the hβ2-AR system 
and Figure S2 has results for the hA2AR system. The correlation between bihelix mean-field 
and trihelix energies holds for most of the trihelix energy range. Big deviations are seen 
between the two energies only in the very high energy (> 500kcal/mol) conformational 
space, seen especially in Figure S1.E for hβ2-AR and Figures S2.B and S2.D for hA2AR. 
Figure S3 shows these three cases with a focus on the lowest 1000 kcal/mol range, which 
shows that the correlation between these two energies holds in the relevant low energy 
range. Next we will look at the BiHelix energies at the seven-helix bundle level.
In the next demonstration of BiHelix, each of the seven-helix bundles was taken through a 
complete sampling of the conformational space using helix rotation angle η as a sampling 
variable. The angle was sampled over full 360° using two grids, a 30° grid and a 15° grid. 
The 30° grid samples ~35 million conformations and the 15° grid samples ~ 4.5 × 109 
conformations. After BiHelix sampling, the top 2000 conformations were taken through 
CombiHelix to produce a final ranking of lowest energy conformations. The results for all 
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six systems are summarized in Table 1, which lists the rank of the crystal conformation 
(XTAL Rank) at the BiHelix level and at the CombiHelix level. It also lists the worst 
BiHelix ranked structure that shows up in the top 10 conformations after CombiHelix.
As can be seen from Table 1, the crystal conformation is ranked “first” for all cases in 30° 
sampling and all but one case in 15° sampling. The exception in the 15° sampling mode is 
for the turkey β1 case, where the crystal conformation is ranked second. These results show 
that the energies used are reliable enough that, upon complete sampling of the 
conformational space they can still identify the lowest energy conformation assumed to be 
the crystal conformation. Since the crystal ligand is absent during sampling (except for 
Bovine Opsin case which is the ligand-free form of Rhodopsin), these results indicate that 
the predicted low-energy GPCR conformations in the absence of ligands are identical to or 
close to those observed experimentally at least in the helix rotation angle η space.
Table 1 also shows the worst BiHelix Rank for the top 10 conformations after the 
CombiHelix step, which is a function of the sampled conformational space as evident by 
higher worst ranks for the 15 degree sampling. Since CombiHelix energies are more 
accurate than those at the BiHelix level, this worst BiHelix Rank also provides a qualitative 
estimate of the accuracy of BiHelix energies for top 10 conformations after CombiHelix. 
Next, we will look at results for some GPCR systems to understand their implications and 
specific correlations between BiHelix/CombiHelix energies and Cα-RMSD of 
conformations to the crystal conformation.
3.B Conformational and Correlation Analysis
First we will look at the top 10 conformations for Bovine Rhodopsin after the application of 
BiHelix/CombiHelix procedure using 30° sampling of helix rotation angle. The top 2000 
conformations from BiHelix were taken through CombiHelix. Table 2 shows the top 20 
conformations after CombiHelix, along with their energy (SCH-Energy) in kcal/mol, 
BiHelix rank (SBHRnk), and BiHelix energy (SBH-Energy) also in kcal/mol. Since the 
starting template was the crystal conformation, that conformation corresponds to all seven η 
angles being “zero” and according to the Table 2 (green cells), it is ranked at the top after 
conformational sampling using BiHelix/CombiHelix. This is a validation of the energies 
being used to rank/score the conformations as well as additional validation of the side-chain 
placement program SCREAM.54 Even though only helix rotation angle was sampled during 
this procedure, the top 20 conformations provide signatures for additional conformations 
that may be important as part of the function of Rhodopsin. First thing that is evident is the 
high conformational flexibility of TM5 in the helix rotational space, which is not 
inconsistent with flexibility associated with TM5 for class A GPCRs. In addition, we see 
counterclockwise 30° rotations in TM3 and TM6 as shown in Table 2 by red cells, which is 
consistent with the helix rotations observed in the Bovine Opsin (the retinal-free form of 
Bovine Rhodopsin) crystal structure, as characterized by the comparison of their templates 
shown in Table S1 in the supplementary information, which shows the Opsin TM3 and TM6 
rotated by −28° and −31° respectively relative to Rhodopsin.
We don’t see a single conformation in the top 2000 that shows both TM3 and TM6 with this 
rotation, because these rotations are also associated with changes in helix tilts (Δϕ column in 
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Table S1) which were not sampled. The results for Bovine Rhodopsin show that: a. BiHelix/
CombiHelix procedure can identify the crystal conformation to be the lowest energy 
conformation; b. The procedure has the potential to identify multiple GPCR conformations 
that may have a physiological role in their function. These results for other 5 systems are 
included in the supplementary information (Tables S2 through S6).
Next we will use human β2 adrenergic receptor system to highlight different correlations 
that are present in the BiHelix/CombiHelix procedure. Figure 3A shows the correlation 
between BiHelix and CombiHelix energies as raw (red) and smoothened (blue) data 
(obtained by using a traveling window average of three points: i−1, i, and i+1, in the y-axis). 
This correlation is good for conformations ranked up to ~200, as expected due to less noise 
in the low-energy regions for both BiHelix and CombiHelix energies. Beyond that range of 
conformations, BiHelix energies flatten out, whereas CombiHelix energies continue to rise.
This is also clear from Figure 3D, which shows BiHelix/CombiHelix energies as a function 
of conformation rank, with BiHelix energies flattening at higher energies (presumably due to 
lack of steric clash in BiHelix) and CombiHelix energies rising steeply at high energies. 
Figure 3B shows the rank correlation between BiHelix and CombiHelix ranks. The raw data 
(in red) fluctuates a lot but the underlying behavior can be extracted by smoothening the raw 
data by a traveling window average using a window size of three points (i−1, i, and i+1) 
shown in blue. The rank correlation of Figure 3B qualitatively mimics the energy based 
correlation in Figure 3A. The correlation between Cα-RMSD of predicted conformations 
(relative to the crystal conformation) versus CombiHelix energy is shown in Figure 3C, as 
this energy determines the final rank of the conformations. It shows a good correlation and 
all high energy conformations have a high Cα-RMSD as well. This correlation should 
breakdown at high Cα-RMSD values as these can have potentially similar energies. The 
corresponding results for other 5 GPCR systems are included in the supplementary 
information (Figures S4 through S8). For predicting multiple GPCR conformations the 
energy and rank correlations of Figures 3A and 3B provide good signatures to assign 
confidence to the predictions.
3.C Helix-Helix interaction potential energy landscapes from BiHelix
The bihelix energies presented in the previous sections can also be used to look at the 
potential energy landscapes that describe helix-helix interactions. This is especially useful 
for the following two related applications: a. It can provide snapshots of energy landscapes 
that these receptors will encounter during the protein folding process, which for all 
membrane proteins is still not very well understood, except for evidence for a “two-stage” 
model for α-helical membrane protein folding55 which suggests that helix formation takes 
place before helix-helix associations can take place in the membrane; b. It can also provide 
vital information about the flexibility in helix-helix packings (in terms of the degree of 
freedom being sampled and accessible conformational space) which when compared across 
related systems with different functional signatures can begin to provide useful insight into 
the structural implications of those functional differences. These implications will now be 
demonstrated using Bovine Rhodopsin and Bovine Opsin as examples bearing in mind that 
the ultimate fate of these observations is determined by the sum of all BiHelix energies.
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Figures 4 and 5 display the potential energy surfaces for all nearest neighbor helix-helix 
interactions as a function of the rotation angles of the corresponding helices for Bovine 
Rhodopsin. Panels A through F in Figure 4 show these surfaces for helix pairs 1-2, 1-7, 2-7, 
2-3, 2-4, and 3-4. Panels A through F in Figure 5 show these surfaces for helix pairs 3-5, 
3-6, 3-7, 4-5, 5-6, and 6-7. These figures only display data for BiHelix conformations that 
are within 100 kcal/mol of the lowest energy conformation in each case. The empty 
conformational space in the figures then refers to high energy conformations, which will be 
assumed to be inaccessible for the current discussions.
The darkest blue regions correspond to the most stable/favorable regions for the involved 
helix pairs. The center point in each panel refers to the (0°, 0°) conformation corresponding 
to the crystal structure. For majority of the helix pairs, the native (crystal structure) 
conformation and near-native conformations fall in the most stable (dark blue) regions. The 
exceptions appear to be helix pairs 3-5 and 3-6 (Figure 5 panels A and B). Helix pairs 4-5 
and 5-6 (Figure 5 panels D and E) have the largest blue area in terms of conformational 
space in helix rotation angles suggesting a flatter energy landscape as compared to all other 
helix pairs.
Helix pairs 1-2, 2-3, and 3-4 (Figure 4 panels A, D, F) have the most inaccessible 
conformational space, which might be due to the necessity to restrict available 
conformations during the protein-folding process given the fact that these helix pairs involve 
the first four helices of the 7-helix bundle. This, however, remains to be verified. This 
observation about large inaccessible conformational space for these helix pairs is also seen 
in the corresponding helix pairs in most of the other GPCR systems studied in this work, 
suggesting something unique or unusual about these helix pairs requiring future 
investigation.
Figures 6 and 7 show the corresponding potential energy surfaces for Bovine Opsin, 
considered to be the near-active GPCR conformation. Figure 6 contains these surfaces for 
helix pairs 1-2, 1-7, 2-7, 2-3, 2-4, and 3-4. Figure 7 contains these surfaces for helix pairs 
3-5, 3-6, 3-7, 4-5, 5-6, and 6-7.
Here also, for majority of the helix pairs, the native (crystal structure) conformation and 
near-native conformations fall in the most stable (dark blue) regions. The exceptions appear 
to be helix pairs 3-7 and 5-6 (Figure 7 panels C and E). Helix pairs 4-5 and 3-6 (Figure 7 
panels D and B) have the largest blue area in terms of conformational space in helix rotation 
angles suggesting a flatter energy landscape as compared to all other helix pairs.
The critical helix-helix contact in Rhodopsin crystal structure appears to be the TM3-TM6 
salt bridge which gets broken upon activation and Opsin (one of the near-active 
conformations downstream of meta Rhodopsin II) displays a TM5-TM6 salt bridge. Energy 
landscapes corresponding to these helix pairs for Rhodopsin and Opsin can provide some 
useful insight. It is curious that crystal conformations for TM5-TM6 Opsin BiHelix pair 
(Figure 7 panel E) and TM3-TM6 Rhodopsin BiHelix pair (Figure 5 panel B) are not in their 
lowest energy regions (dark blue), so interactions with other helices play a dominant role in 
making the crystal conformation more stable and attain lowest energy. Since the BiHelix 
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method implicitly takes into account the effect of non-nearest-neighbor helices when we 
combine all the two-helix energies to get seven-helix bundle energies, the BiHelix/
CombiHelix energies are able to correct this curious observation at the seven-helix bundle 
level. This is a testament to the strength of the BiHelix/CombiHelix method. In addition, the 
TM3-TM6 BiHelix pair exhibits a flat energy landscape in Opsin (Figure 7 panel B), 
consistent with its crystal structure which as described above shows that the TM3-TM6 
Rhodopsin contact is broken in Opsin. It is the TM5-TM6 BiHelix pair that exhibits this flat 
energy landscape for Rhodopsin (Figure 5 panel E) consistent with its crystal structure 
showing a TM3-TM6 salt-bridge and a broken TM5-TM6 contact. This same BiHelix pair 
(TM5-TM6) exhibits a restricted landscape for Opsin (Figure 7 panel E), not inconsistent 
with its crystal structure showing stronger coupling between helices 5 and 6. This doesn’t 
appear to be the case for the analogous case in Rhodopsin (TM3-TM6, Figure 5 panel B), 
suggesting a stronger involvement of other helices (compared to Opsin) in restricting TM3-
TM6 to the crystal conformation. These analyses suggest that connecting the energy 
landscapes with functional information about different receptors can begin to provide 
valuable mechanistic insight into the function of these receptors.
Opsin also displays Helix pairs 1-2, 2-3, and 3-4 (Figure 7 panels A, D, F) with the most 
inaccessible conformational space like Rhodopsin. The supplementary information contains 
the corresponding potential energy surfaces for other 4 systems studied: β2, β1, A2AR, 
SquidRhod (see Figures S9 through S16), which also share this observation. There is a 
wealth of information in all these landscapes which is currently being investigated. So, in 
addition to structure prediction, the BiHelix methodology can help rationalize functional 
behavior with structural insights and may even be helpful in protein folding studies of 
GPCRs.
In terms of computational resources consumed by BiHelix and Combihelix, the BiHelix 
sampling of 1728 two-helix conformations (on the η grid of 30°) is fast and takes about 2 
hours on 12 Xeon 2.33GHz processors, whereas the CombiHelix sampling of top 2000 
conformations (from the BiHelix step) takes about 16 hours on 12 processors, as this step 
now involves the optimization of residue side-chains on all seven helices along with 
minimization.
4. CONCLUSIONS
We have presented the BiHelix/CombiHelix methodology aimed towards de novo structure 
prediction of multiple conformations of helical membrane proteins using GPCRs as the 
example applications. The methodology efficiently performs a complete sampling of the 
available conformational space by breaking the full helix bundle into multiple pairs of 
interacting helices, whose energies are pooled together to get the energies of all 
conformations of the full helix bundle. Application of this approach to six of the available 
GPCRs is able to identify native and near-native conformations as the top conformations by 
energy. These results validate the sampling method as well as the scoring energy for 
assessing the best bundle conformations. The demonstrated sampling of helix rotation angles 
for Bovine Rhodopsin showed that the methodology can identify other physiologically 
important conformations for a GPCR. We expect that several of the best 10 or 20 predicted 
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structures from BiHelix/CombiHelix conformational sampling might play a role in 
differential binding of agonists, antagonists and inverse agonists or in activation pathways. 
The BiHelix energy landscapes are also capable of providing structural insights into 
functionally different receptors as demonstrated for Rhodopsin vs Opsin comparisons.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Coordinates specifying the orientation of a TM helix in a membrane.
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Figure 2. 
A. Typical seven-helix bundle. B. Nearest-neighbor helix pairs highlighted by double 
arrows; C. The 12 helix pairs shown explicitly.
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Figure 3. 
A. Correlation between CombiHelix energies and BiHelix energies of the predicted helix 
bundle conformations, raw data (in red) and smoothed data using ±1 data points (in blue); B. 
Correlation between CombiHelix Rank and BiHelix Rank of the predicted conformations 
(colors same as in panel A); C. Correlation between CombiHelix energies and the 
corresponding Ca-RMSD of those conformations relative to the conformation observed in 
the crystal structure (PDBid: 2rh1) (colors same as in panel A); D. BiHelix (Blue) and 
CombiHelix (Red) energies as a function of Conformation Rank.
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Figure 4. 
Bovine Rhodopsin potential energy surfaces for helix pairs TM1-TM2 (A), TM1-TM7 (B), 
TM2-TM7 (C), TM2-TM3 (D), TM2-TM4 (E), and TM3-TM4 (F) as a function of helix 
rotation angles for corresponding helices. The energies are in kcal/mol, where the colorbar 
under each panel shows the lowest 100 kcal/mol energy range.
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Figure 5. 
Same as Figure 4 for helix pairs TM3-TM5 (A), TM3-TM6 (B), TM3-TM7 (C), TM4-TM5 
(D), TM5-TM6 (E), and TM6-TM7 (F).
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Figure 6. 
Same as Figure 4 for Bovine Opsin.
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Figure 7. 
Same as Figure 5 for Bovine Opsin.
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